ConductScience.org, home

Paper38758596

The Evolution of Antibody-Drug Conjugates: Toward Accurate DAR and Multi-specificity.

Dong W and 2 others. ChemMedChem, 2024. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. The Evolution of Antibody-Drug Conjugates: Toward Accurate DAR and Multi-specificity. Papers, record 38758596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38758596

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Evolution of Antibody-Drug Conjugates: Toward Accurate DAR and Multi-specificity.
PubMed
Journal
ChemMedChem
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
4.55, provisional
iCite
Revised in PubMed
2024-09-02
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dong WWenge
2Wang WWanqi
3Cao CChanhttps://orcid.org/0000-0001-7023-8418

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ImmunoconjugatesMajor topic
Humans
Neoplasms
Antineoplastic Agents
Drug Resistance, Neoplasm

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
22177053National Natural Science Foundation of ChinaPubMed
32371291National Natural Science Foundation of ChinaPubMed
2023YFD1802300National Key Research and Development Program of ChinaPubMed
2021QNRC001Young Elite Scientist Sponsorship Program by CASTPubMed
2122021353Fundamental Research Funds for the Central Universities, Nankai UniversityPubMed

Source PubMed

Download CSV of grants

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42654071Linker Design in Antibody-Drug Conjugates: Balancing Stability and Drug Release.Pharmaceutics2026https://conductscience.org/library/papers/42654071PubMed
42619145Targeting Adaptive and Innate Immune Responses with Covalent Aptamers.J Am Chem Soc2026https://conductscience.org/library/papers/42619145PubMed
42559290Antibody-Drug Conjugates and Peptide-Drug Conjugates: Current Understandings and Future Perspectives.MedComm (2020)2026https://conductscience.org/library/papers/42559290PubMed
42514927Peptide-Drug Conjugates for Targeted Delivery in Hematological Malignancies: From Design Principles to Clinical Application.Pharmaceutics2026https://conductscience.org/library/papers/42514927PubMed
42385135Recent Progress in Antimicrobial Peptides (AMPs) Towards Enhanced Selectivity and Reduced Cytotoxicity by Molecular Engineering.Biotechnol Bioeng2026https://conductscience.org/library/papers/42385135PubMed
42351118Antibody-drug conjugates in breast cancer: from mechanism to revolutionizing clinical practice.Mol Cancer2026https://conductscience.org/library/papers/42351118PubMed
42042562Antibody-Drug Conjugates in Gastrointestinal Oncology: Clinical Efficacy and Inpatient Toxicity Management.J Pers Med2026https://conductscience.org/library/papers/42042562PubMed
41799094Site-Specific Glycan Conjugation Improves Stability and Efficacy of an Antibody-Drug Conjugates Bearing DXd as a Cytotoxic Payload.ACS Omega2026https://conductscience.org/library/papers/41799094PubMed
41789080Clinical applications of antibody-drug conjugates in advanced non-small cell lung cancer.Front Immunol2026https://conductscience.org/library/papers/41789080PubMed
41709436Antibody-Antibiotic Conjugates: Mechanisms, Clinical Progress, and Next-Generation Strategies Against Multidrug-Resistant Bacterial Infections.Microbiologyopen2026https://conductscience.org/library/papers/41709436PubMed
41560806Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates.Mater Today Bio2026https://conductscience.org/library/papers/41560806PubMed
41518796Mechanisms of resistance to antibody-drug conjugates in breast cancer.Drug Resist Updat2026https://conductscience.org/library/papers/41518796PubMed
41463194Antibody-Drug Conjugates and Beyond: Next-Generation Targeted Therapies for Breast Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/41463194PubMed
41275230A high-affinity CEA-targeted nanobody for 68Ga PET imaging and 177Lu-based radioisotope therapy: preclinical and first-in-human evaluation.J Nanobiotechnology2025https://conductscience.org/library/papers/41275230PubMed
41184856Antibody-drug conjugates in cancer therapy: current landscape, challenges, and future directions.Mol Cancer2025https://conductscience.org/library/papers/41184856PubMed
41022825Antibody-drug conjugates in breast cancer: mechanisms of resistance and future therapeutic perspectives.NPJ Breast Cancer2025https://conductscience.org/library/papers/41022825PubMed
40843358The next frontier in antibody-drug conjugates: challenges and opportunities in cancer and autoimmune therapy.Cancer Drug Resist2025https://conductscience.org/library/papers/40843358PubMed
40491603Overview of antibody-drug conjugates nonclinical and clinical toxicities and related contributing factors.Antib Ther2025https://conductscience.org/library/papers/40491603PubMed
40307936Antibody-Drug Conjugates (ADCs): current and future biopharmaceuticals.J Hematol Oncol2025https://conductscience.org/library/papers/40307936PubMed
40052373Methods for the Generation of Single-Payload Antibody-Drug Conjugates.ChemMedChem2025https://conductscience.org/library/papers/40052373PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38758596

GET https://conductscience.org/api/papers/v1/38758596/cited_by?page=2